NRC-2023-0174, Comment (1) of Anonymous Individual on Accelerated Decommissioning Partners Crystal River Unit 3, LLC; Crystal River Unit 3; License Termination Plan
| ML24074A464 | |
| Person / Time | |
|---|---|
| Site: | Crystal River  |
| Issue date: | 03/07/2024 |
| From: | - No Known Affiliation |
| To: | Office of Administration |
| References | |
| NRC-2023-0174, 88FR77111 00001 | |
| Download: ML24074A464 (1) | |
Text
3/14/24, 957 AM blobhttps//wwwfdmsgov/53a21d90150146efb5154ace53e81835
SUNSI Review Complete As of: 3/14/24, 9:56 AM Template=ADM-013 Received: March 07, 2024 E-RIDS=ADM-03 PUBLIC SUBMISSIONADD: Tim Barvitskie, Jack Status: Pending Post Parrott, Sarah Achten, Mary Tracking No. lth-js64-u3jw Neely Comments Due: March 07, 2024 Comment (1) Submission Type: Web Publication Date: 11/8/2023 Citation: 88 FR 77111 Docket: NRC-2023-0174 Accelerated Decommissioning Partners Crystal River Unit 3, LLC; Crystal River Unit 3; License Termination Plan
Comment On: NRC-2023-0174-0001 Accelerated Decommissioning Partners Crystal River Unit 3, LLC; Crystal River Unit 3 Nuclear Generating Plant; License Termination Plan
Document: NRC-2023-0174-DRAFT-0001 Comment on FR Doc # 2023-24620
Submitter Information
Name: Anonymous Anonymous Email:
General Comment
The staff assigned within ADPCR3 have limited experience with the current methodologies for performing the radiological dose calculations associated with a License Termination. This is apparent from the limited detail on how the calculations will be performed that has been provided to date in licensee submittals. Recent License Terminations at Zion, LaCrosse, and Humboldt Bay have shown that without the appropriate level of analytical experience on staff that the process and time required to complete this work can extend the total time to terminate a license by many years. The ADPCR3 staff has limited experience with collecting radiological samples but no recent experience with performing the calculations required to demonstrate that the final dose will comply with the 10 CFR 20.1402 dose limit.
blobhttps//wwwfdmsgov/53a21d90150146efb5154ace53e81835 1/1